(Q36761526)

16 August 2017

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling (English)

1 reference

16 August 2017

Andrea Pellagatti

15

0 references

Gang Liu

Gang Liu

21

0 references

Jacqueline Boultwood

Jacqueline Boultwood

16

0 references

Alan F List

Alan List

23

0 references

Tushar D Bhagat

1

Tushar D Bhagat

1 reference

16 August 2017

18

Ulrich Steidl

1 reference

16 August 2017

17

Suman Kambhampati

1 reference

16 August 2017

8

Shanisha Gordon

1 reference

16 August 2017

7

Roni Tamari

1 reference

16 August 2017

3

Lubomir Sokol

1 reference

16 August 2017

5

Gisela Caceres

1 reference

16 August 2017

6

Krishna Gundabolu

1 reference

16 August 2017

9

Ioannis Mantzaris

1 reference

16 August 2017

24

Markus Bitzer

1 reference

16 August 2017

Li Zhou

2

1 reference

16 August 2017

Rachel Kessel

4

1 reference

16 August 2017

Tomasz Jodlowski

10

1 reference

16 August 2017

Yiting Yu

11

1 reference

16 August 2017

Xiaohong Jing

12

1 reference

16 August 2017

Rahul Polineni

13

1 reference

16 August 2017

Kavi Bhatia

14

1 reference

16 August 2017

Cy Stein

19

1 reference

16 August 2017

Wenjun Ju

20

1 reference

16 August 2017

Paraic Kenny

22

1 reference

16 August 2017

Amit Verma

25

1 reference

16 August 2017

language of work or name

English

0 references

publication date

6 February 2013

1 reference

16 August 2017

7

1 reference

inferred from page(s)

published in

Blood

1 reference

16 August 2017

121

1 reference

16 August 2017

15

1 reference

16 August 2017

2875-2881

1 reference

Quantitative analysis of miRNA expression in epithelial cells and tissues.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Frequent pathway mutations of splicing machinery in myelodysplasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Causes and consequences of microRNA dysregulation in cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Apoptosis in the myelodysplastic syndromes.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

International scoring system for evaluating prognosis in myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Biologic nature of the myelodysplastic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Decreased level of transforming growth factor-beta in blood lymphocytes of patients with aplastic anemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Prognostic factors and scoring systems in myelodysplastic syndromes.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3624935

Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

5 September 2018

1 reference

12 December 2020

Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes

1 reference

12 December 2020

Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome

1 reference

12 December 2020

Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia

1 reference

12 December 2020

Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis

1 reference

12 December 2020

TGF beta signaling in health and disease

1 reference

12 December 2020

Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes

1 reference

12 December 2020

Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis

1 reference

12 December 2020

Genetic polymorphisms in patients with myelodysplastic syndrome

1 reference

12 December 2020

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

1 reference

12 December 2020

Polymorphisms in TGFbeta and TNFalpha are associated with the myelodysplastic syndrome phenotype

1 reference

12 December 2020

Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders

1 reference

12 December 2020

10.1182/BLOOD-2011-12-397067

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

1 reference